<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="44185">Methotrexate</z:chebi> (MTX) is widely used in the treatment of <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The typical side-effects of high-dose MTX chemotherapy on the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> range from asymptomatic white matter changes to severe <z:hpo ids='HP_0007305'>CNS demyelination</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>MTX neuro - toxicity has been described to be associated with <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and <z:chebi fb="3" ids="37445">folate</z:chebi> levels as well as genetic variants affecting methionine metabolism </plain></SENT>
<SENT sid="3" pm="."><plain>Here we describe a case of severe, <z:hpo ids='HP_0011009'>acute</z:hpo> MTX-induced <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> in a patient who was found to be homozygous for the rare missense variant methionine synthase (MTR) c.2756A&gt;G (D919G), which may have modified the effect of MTX on <z:chebi fb="0" ids="17230">homocysteine</z:chebi> metabolism </plain></SENT>
<SENT sid="4" pm="."><plain>This finding encourages further studies to determine to what extent the individual conditions of <z:chebi fb="3" ids="37445">folate</z:chebi> and methionine metabolism influence the effects or side-effects of MTX treatment </plain></SENT>
</text></document>